| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000031574 |
| Receipt No. | R000036051 |
| Official scientific title of the study | Study on the association of reflux esophagitis and oral microbiota. |
| Date of disclosure of the study information | 2018/03/05 |
| Last modified on | 2018/03/05 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Study on the association of reflux esophagitis and oral microbiota. | |
| Title of the study (Brief title) | Influence of oral microbiota for reflux esophagitis | |
| Region |
|
|
| Condition | ||
| Condition | Reflux esophagitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of the present study was to identify the specific pathogen about reflux esophagitis. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Healthy volunteers, patients with reflux esophagitis or eosinophilic esophagitis donated the fecal, saliva, periodontal pocket fluid and scraching samples of esophagus mucous. We then investigate the bacterial communities using 16S rRNA gene sequencing method. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) over 20 year old
2) Informed consent about this research has been obtained with participants in writing form. |
|||
| Key exclusion criteria | 1) daily usage of steroids, immunosuppresive and anticancer drugs
2) 20 or fewer teeth 3) using antibiotics during use or within 1 month 4) During pregnancy, lactating, a woman who may be pregnant 5) history of allergy to proton pump inhibitor 6) A case of a history of resection of the gastrointestinal tract except for appendectomy 7) the research director judged inappropriate as the subject of this resea |
|||
| Target sample size | 72 | |||
| Research contact person | |
| Name of lead principal investigator | Tsuyoshi Mishiro |
| Organization | Shimane university school of medicine |
| Division name | Division of gastroenterology |
| Address | 89-1 Enya-cho, Izumo, Shimane, Japan |
| TEL | 0853-20-2190 |
| tmishiro@med.shimane-u.ac.jp | |
| Public contact | |
| Name of contact person | Tsuyoshi Mishiro |
| Organization | Shimane university school of medicine |
| Division name | Division of gastroenterology |
| Address | 89-1 Enya-cho, Izumo, Shimane, Japan |
| TEL | 0853-20-2190 |
| Homepage URL | |
| tmishiro@med.shimane-u.ac.jp | |
| Sponsor | |
| Institute | Shimane university school of medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Healthy volunteers, patients with reflux esophagitis or eosinophilic esophagitis donated the fecal, saliva, periodontal pocket fluid and scraching samples of esophagus mucous. We then investigate the bacterial communities using 16S rRNA gene sequencing method. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036051 |